The starting age dropped, a blood test joined the list, and there's now an age doctors say to quit.
Mail-based screening programs are helping more Americans stay up to date with colorectal cancer tests—often with a simple box ...
Sean Stalker thought he was healthy. At 44, he worked out four days a week and stayed active with his children. But one ...
SAN DIEGO — In the ever-expanding options for colorectal cancer (CRC) screening, blood tests using precision medicine are becoming more advanced and convenient than ever; however, caveats abound, and ...
The SimpleScreen CRC blood test, developed by Freenome, will be sold exclusively by Abbott alongside its Cologuard Plus home ...
More cases of colorectal cancer are detected at an early stage with screening. This is according to new research based on data from over 278,000 60-year-olds, who were randomly selected to undergo one ...
Abbott (NYSE: ABT) today announced the U.S. commercial launch of SimpleScreenâ„¢ CRC, an FDA-approved blood-based colorectal cancer (CRC) screening test for adults age 45 and older who are at average ...
Tens of millions of middle-aged and older Americans haven't gotten their recommended checks for early signs of potential colon cancer, either through the "gold standard" of colonoscopy or a ...
Current US FDA-cleared stool-based colorectal cancer (CRC) molecular screening tests include fecal immunochemical tests (FIT) for occult blood detection; however, integration with nucleic acid-based ...
WovenX Health, a Chicago-based specialty care platform, today announced a GI procedure partner network spanning all 50 states and Washington, D.C., supporting the launch of a national colorectal ...
Forbes contributors publish independent expert analyses and insights. Physician who writes about the rising rates of cancer in young adults. This voice experience is generated by AI. Learn more. This ...
Invitations to patients eligible for colorectal cancer screening need not be limited to office visits. A 2018 systematic review and meta-analysis of 73 randomized clinical trials of U.S.-based ...